Novato, CA, United States of America

Shinong Long

USPTO Granted Patents = 11 


 

Average Co-Inventor Count = 7.0

ph-index = 5

Forward Citations = 68(Granted Patents)


Location History:

  • Milpitas, CA (US) (2012 - 2013)
  • San Ramon, CA (US) (2016 - 2018)
  • Novato, CA (US) (2017 - 2022)

Company Filing History:


Years Active: 2012-2022

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Of course! Here is the article about inventor Shinong Long:

Title: Shinong Long: Pioneering Innovations in Therapeutic Fusion Proteins and Pharmaceutical Variants

Introduction:

Shinong Long is a distinguished inventor based in Novato, CA (US) who has made significant contributions to the field of medical biotechnology. With a portfolio boasting 11 patents, Long's work has been pivotal in developing targeted therapeutic lysosomal enzyme fusion proteins and pharmaceutical variants of C-type natriuretic peptide.

Latest Patents:

Long's latest patents showcase his expertise in creating innovative solutions for challenging medical conditions. One of them includes the development of targeted therapeutic lysosomal enzyme fusion proteins for the treatment of lysosomal storage diseases, specifically focusing on Mucopolysaccharidosis Type IIIB (Sanfilippo B Syndrome). These fusion proteins combine a lysosomal enzyme, a lysosomal targeting moiety like an IGF-II peptide, and a spacer peptide for enhanced efficacy.

Another groundbreaking patent by Long introduces variants of C-type natriuretic peptide, which have shown promise in treating diseases that respond to CNP. These variants have proven effective in addressing bone-related disorders such as skeletal dysplasias and vascular smooth muscle disorders like restenosis and arteriosclerosis.

Career Highlights:

Long is associated with Biomarin Pharmaceutical Inc., a renowned biopharmaceutical company known for its cutting-edge research and development in rare genetic diseases. His tenure at Biomarin Pharmaceutical Inc. has been marked by a series of innovative patents that have pushed the boundaries of medical science.

Collaborations:

In his research endeavors, Long has collaborated closely with esteemed colleagues such as Daniel J Wendt and Mika Aoyagi-Scharber. Together, they have formed a formidable team dedicated to advancing medical treatments and improving patient outcomes through groundbreaking inventions.

Conclusion:

Shinong Long stands as a beacon of innovation in the realm of medical biotechnology, with a rich legacy of patents that have the potential to revolutionize the treatment of complex diseases. His steadfast dedication to pushing the boundaries of scientific knowledge underscores his commitment to improving the quality of life for patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…